NCT03560063

Brief Summary

The primary objective of this study is to determine whether the Corin Optimised Positioning System (Corin, U.K.) reduces the rate of hip dislocation at one-year post-operatively compared with standard templating in patients undergoing total hip replacement. The secondary objectives of this study are to determine whether the Corin Optimised Positioning System (Corin, U.K.) improves functional outcomes, reduces length of hospital stay, and reduces leg length discrepancy compared with standard templating in patients undergoing total hip replacement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
460

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

May 23, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 18, 2018

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

March 29, 2019

Status Verified

May 1, 2018

Enrollment Period

3 years

First QC Date

May 23, 2018

Last Update Submit

March 27, 2019

Conditions

Keywords

arthroplastydislocationtemplating

Outcome Measures

Primary Outcomes (1)

  • Dislocation rate

    Incidence of hip dislocation within 12 months post-operatively

    12 months

Secondary Outcomes (10)

  • Change in Harris Hip Score

    Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively

  • Change in Oxford Hip Score

    Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively

  • Change in Hip and Groin Outcome Score

    Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively

  • Change in International Hip Outcome Tool 33 (iHOT33) Score

    Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively

  • Change in EuroQol 5 dimension (EQ5D) Score

    Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively

  • +5 more secondary outcomes

Study Arms (2)

Corin OPS arm

EXPERIMENTAL

Total hip replacement with use of Corin Optimised Positioning System to guide implant positioning

Procedure: Corin Optimised Positioning System

Standard care arm

ACTIVE COMPARATOR

Total hip replacement with standard templating to guide implant positioning

Procedure: Standard templating

Interventions

Total hip replacement with implant positioning guided by Corin Optimised Positioning System. The experimental and active comparator arms will use the same implants for total hip replacements. The Corin Trinity shell system will be used for the acetabular system. The Corin MiniHip, TriFit, MetaFix and TaperFit implants will be used for the femoral stem implant. Surgeons will select the implant most appropriate for each patient.

Also known as: K171847
Corin OPS arm

Total hip replacement with implant positioning guided by standard templating. The experimental and active comparator arms will use the same implants for total hip replacements. The Corin Trinity shell system will be used for the acetabular system. The Corin MiniHip, TriFit, MetaFix and TaperFit implants will be used for the femoral stem implant. Surgeons will select the implant most appropriate for each patient.

Also known as: Anteroposterior and lateral hip radiographs
Standard care arm

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the trial
  • Diagnosed with hip OA, post-traumatic OA, inflammatory arthropathy, avascular necrosis, or congenital or developmental hip disease, avascular necrosis of the hip
  • Listed for total hip arthroplasty at one of participating centres
  • Participant is fit to undergo total hip arthroplasty based on consultant anaesthetist review
  • In the Investigator's opinion, is able and willing to comply with all trial requirements
  • Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial
  • Female participants of child bearing potential must be willing to ensure that they use effective contraception during the trial

You may not qualify if:

  • Inability to provide informed consent
  • Previous surgery to the ipsilateral hip
  • Significant co-morbidities that would make follow up difficult or uncomfortable
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the trial
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nuffield Orthopaedic Centre, Oxford University Hospitals Trust

Oxford, OX3 7LD, United Kingdom

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, HipOsteoarthritisArthritisMusculoskeletal DiseasesJoint Dislocations

Condition Hierarchy (Ancestors)

Joint DiseasesRheumatic DiseasesWounds and Injuries

Study Officials

  • Sion Glyn-Jones, DPhil FRCS

    University of Oxford

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants: participants in both arms will undergo total hip replacement while under general anaesthetic. Participants will not be aware of the templating method used during the total hip replacement due to the general anaesthetic, therefore will remain blinded. Wounds and dressings will be the same for both study arms. Participants in the two study arms will undergo the same pre- and post-operative imaging to prevent unmasking. Outcomes assessors examine patients from 3 months post-operatively. There is no risk they will know which arm the patient is in, as they will not have access to the study database.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be recruited and randomised into the two parallel study arms. Interventional arm: total hip replacement with use of the Corin Optimised Positioning System to guide templating. Comparator arm: total hip replacement, guided by standard templating techniques
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2018

First Posted

June 18, 2018

Study Start

May 1, 2018

Primary Completion

May 1, 2021

Study Completion

May 1, 2022

Last Updated

March 29, 2019

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measures will be made available.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be available within 6 months of study completion
Access Criteria
Data access requests will be reviewed by the trial steering committee. Requestors will be required to sign a data access agreement

Locations